Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vimal Arora

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Scientific Reports|February 6, 2026
Nanomagnetic picolylamine- based complex of palladium as an efficient heterogeneous catalyst for selective reduction of nitroarenes in waterAmmar Yasir Ahmed, Hamad AlMohamadi, Hazem Saed Zabibah, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 2026
Disrupting immune silence: Noncoding RNAs targeting the programmed cell death protein 1/programmed cell death ligand 1 axis in tumor immunityChou-Yi Hsu, Ahmed Hjazi, Muath Suliman, et al.
Immunology|May 22, 2026
Reprogramming Autophagy to Strengthen Antitumour Immunity: Advances in Immunotherapeutic StrategiesHamzeh J Al Ameer, Renuka Jyothi S, Israa Abdulhameed Ahmad, et al.
IUBMB Life|April 15, 2026
Self-Assembled Nanovaccines: A Promising Strategy for Overcoming Influenza Variability and Advancing Universal Vaccine DevelopmentChou-Yi Hsu, Ihab M Abdelrahim, Ahmed Hjazi, et al.
Critical Reviews in Oncology/Hematology|December 15, 2025
Phage therapy in cancer treatment: Mechanisms, emerging innovations, and translational progressChou-Yi Hsu, Djamila Polatova, Rania Hameed Hamad, et al.
Critical Reviews in Oncology/Hematology|February 25, 2026
" Pharmacomicrobiomics in blood cancers: how the gut microbiome and its metabolites shape drug efficacy and toxicity "Chou-Yi Hsu, Yasir Qasim Almajidi, Mohammad Abohassan, et al.
Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences|June 29, 2026
Therapeutic targeting of COX-2 in head and neck cancer: Mechanistic and clinical perspectivesReena Gupta, Bilal Khaleel Midhin, Sabir Ali Siddiqui, et al.
DNA and Cell Biology|February 23, 2026
MAPK Signaling and the Tumor Microenvironment: Drivers of Cancer Development and ResistanceHamza Abu Owida, Suleiman Ibrahim Mohammad, Pareshkumar N Patel, et al.
Clinical and Experimental Medicine|June 18, 2026
Engineered small extracellular vesicles in hematologic malignancies: mechanisms, therapeutic strategies, and translational challengesChou-Yi Hsu, Saidmurodkhon Murtazaev, Sally Hassan Zubair, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 26, 2026
Nanomedicine strategies targeting STAT3 in cancer: From tumor suppression to microenvironment modulationZouaouia Chama, Ahlam Yaseen Yousif, Pareshkumar N Patel, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Scientific Reports|February 6, 2026
Nanomagnetic picolylamine- based complex of palladium as an efficient heterogeneous catalyst for selective reduction of nitroarenes in waterAmmar Yasir Ahmed, Hamad AlMohamadi, Hazem Saed Zabibah, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 2026
Disrupting immune silence: Noncoding RNAs targeting the programmed cell death protein 1/programmed cell death ligand 1 axis in tumor immunityChou-Yi Hsu, Ahmed Hjazi, Muath Suliman, et al.
Immunology|May 22, 2026
Reprogramming Autophagy to Strengthen Antitumour Immunity: Advances in Immunotherapeutic StrategiesHamzeh J Al Ameer, Renuka Jyothi S, Israa Abdulhameed Ahmad, et al.
IUBMB Life|April 15, 2026
Self-Assembled Nanovaccines: A Promising Strategy for Overcoming Influenza Variability and Advancing Universal Vaccine DevelopmentChou-Yi Hsu, Ihab M Abdelrahim, Ahmed Hjazi, et al.
Critical Reviews in Oncology/Hematology|December 15, 2025
Phage therapy in cancer treatment: Mechanisms, emerging innovations, and translational progressChou-Yi Hsu, Djamila Polatova, Rania Hameed Hamad, et al.
Critical Reviews in Oncology/Hematology|February 25, 2026
" Pharmacomicrobiomics in blood cancers: how the gut microbiome and its metabolites shape drug efficacy and toxicity "Chou-Yi Hsu, Yasir Qasim Almajidi, Mohammad Abohassan, et al.
Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences|June 29, 2026
Therapeutic targeting of COX-2 in head and neck cancer: Mechanistic and clinical perspectivesReena Gupta, Bilal Khaleel Midhin, Sabir Ali Siddiqui, et al.
DNA and Cell Biology|February 23, 2026
MAPK Signaling and the Tumor Microenvironment: Drivers of Cancer Development and ResistanceHamza Abu Owida, Suleiman Ibrahim Mohammad, Pareshkumar N Patel, et al.
Clinical and Experimental Medicine|June 18, 2026
Engineered small extracellular vesicles in hematologic malignancies: mechanisms, therapeutic strategies, and translational challengesChou-Yi Hsu, Saidmurodkhon Murtazaev, Sally Hassan Zubair, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 26, 2026
Nanomedicine strategies targeting STAT3 in cancer: From tumor suppression to microenvironment modulationZouaouia Chama, Ahlam Yaseen Yousif, Pareshkumar N Patel, et al.
Pageof 8